Our newsletter is back for its second issue
REPO4EU has just reached its one-year milestone and what better way to celebrate than with a new installment of our official newsletter? Here's a sneak peek of what you'll find inside:
- The latest news on RExPO23 - the international conference on Systems Medicine, AI and Drug Repurposing coming to Stockholm this October 25-26.
- How to join our thriving drug repurposing community to get access to expert insights and matchmaking opportunities.
- An overview of our brand new one-stop publishing platform: Drug Repurposing Central
- Our collection of Knowledge Pills: a series of short explainer videos covering the core concepts behind REPO4EU
- Recap highlights from our recent meetings with the EMA Innovation Task Force and our Project Officer.
Click here to navigate to our second issue and don't forget to subscribe!
Photo by Rinck Content Studio on Unsplash
REPO4EU celebrates its first anniversary after reaching key milestones in a year
One year has passed since the official launch of REPO4EU back on the 1st of September 2022, where all 28 partners met in Maastricht to kick-off the project and lay out the foundations for the upcoming 7 years.
To celebrate the occasion and mark the achievements of our first year working together, we spoke with our Project Coordinator, Prof. Harald Schmidt, to get some first-hand insights into the developments of the past 12 months.
What have we achieved in this first year of REPO4EU?
It’s an honor, and also a big responsibility, to be leading this giant project supported by the European Union, where we’re bringing together scientists and stakeholders from all fields, including bioinformatics, biomedicine, clinicians, patent attorneys and many more; and also, very importantly, to be actively engaging patients in our conversations.
One of the biggest achievements of this year is the development of our online, open access and totally free platform called Drug Repurposing Central — a publishing and communication platform developed in collaboration with ScienceOpen for the whole drug repurposing community.
Drug repurposing is a giant movement spanning medicine worldwide, which is why building a global-reaching community is one of the main objectives for REPO4EU. This year alone, we’ve expanded across Europe but we’re also reaching into Australia, Asia and the Americas, collaborating hand-in-hand with peers and organisations whose work also focuses on advancing patient-centric and precise drug repurposing. Check out who has joined our community so far!
What’s next for REPO4EU?
With our project being centered around exploring the latest technologies for mechanism-based drug repurposing, our research and conversations revolve around using drugs that are already on the market for new indications, always having patients’ needs at the forefront. For this, we’re using the most modern methods of bioinformatics to not only redefine diseases, but to also make sure we’re curing patients — instead of simply treating their symptoms.
After the hard work of this first year, we’re now in the process of preparing the first clinical trials, which will set the path for our upcoming and continuous research into drug repurposing using Machine Learning and other AI-powered tools. Thanks to our recently completed deliverables, we will now also be able to start developing new methods and tools that will become available for colleagues and researchers working within the context of drug repurposing.
Our most exciting plan coming up soon is RExPO23, the second installment in our series of international conferences dedicated to Systems Medicine, AI and Drug Repurposing. This year, we’re going bigger, better and bolder! Those interested in joining us in Stockholm on 25-26 October 2023, can book their tickets now. I hope to see you there!
-
Big thanks to all 28 partners in the REPO4EU consortium for their work so far. Here’s to continuing our mission to move from imprecise drug therapy to precision medicine!
Introducing our official newsletter
At REPO4EU we are starting the new year in style - and what better way to do that than with the launch of our official quarterly newsletter?
Ever since REPO4EU kicked-off, we have been setting the stage for what we believe will be the future - mechanism-based drug repurposing. Read on to discover the main highlights from our work these past 5 months as presented by our coordinator, Prof. Harald Schmidt. In this first issue you’ll find insights from our experts on ethics and AI, the project’s ongoing clinical trials and our contributions to the regulatory and legal landscape surrounding drug repurposing.
We’re also delighted to share a sneak peek on upcoming dissemination activities with the community - stay tuned for updates on REPO4EU’s open publishing portal and our national events to showcase the project in Spain, Germany, Austria and Sweden!
Sounds interesting? Click here to check out the full newsletter and make sure to subscribe!
Photo by Luca Onniboni on Unsplash
Check out our video compilation for RExPO22
Welcome to the revolution!
120+ attendees, 40+ speakers, 11 posters in show and 42 publications...
RExPO22 wrapped up in September and we're already looking forward to the next one. In the meantime, check out the official video compilation below to revisit the first international conference on drug repurposing!
REPO4EU begins its journey to push the boundaries of drug repurposing
It's official - REPO4EU has launched!
This September 1st, all 28 partners met in Maastricht for the very first time to kick-off this flagship Horizon Europe initiative. And we did it in style, celebrating the birth of RExPO22 - the initial installment in the RExPO international conference series on drug repurposing.
Here’s to the next 7 years!
Our first press release is out!
Many exciting things are on the horizon for this September that we would like to share with everyone in the drug repurposing community!
REPO4EU - the Euro-Global platform for Mechanism-based Drug Repurposing is officially kicking off next month and with it also comes to life RExPO22 - the first international conference on drug repurposing.
You can read all about it in our first joint press release!